Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jeremy P. Feldman"'
Autor:
Hunter Gillies, Murali M. Chakinala, Benjamin T. Dake, Jeremy P. Feldman, Marius M. Hoeper, Marc Humbert, Zhi‐Cheng Jing, Jonathan Langley, Vallerie V. McLaughlin, Ralph W. Niven, Stephan Rosenkranz, Xiaosha Zhang, Nicholas S. Hill
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract AV‐101 (imatinib) powder for inhalation, an investigational dry powder inhaled formulation of imatinib designed to target the underlying pathobiology of pulmonary arterial hypertension, was generally well tolerated in healthy adults in a p
Externí odkaz:
https://doaj.org/article/6cca6181d66a4a5aadc281acfa6b68ed
Autor:
Hunter Gillies, Ralph Niven, Benjamin T. Dake, Murali M. Chakinala, Jeremy P. Feldman, Nicholas S. Hill, Marius M. Hoeper, Marc Humbert, Vallerie V. McLaughlin, Martin Kankam
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
Background Oral imatinib has been shown to be effective, but poorly tolerated, in patients with advanced pulmonary arterial hypertension (PAH). To maintain efficacy while improving tolerability, AV-101, a dry powder inhaled formulation of imatinib, w
Externí odkaz:
https://doaj.org/article/6e8ff00f40604cb1bb338a1660e59c87
Autor:
Jasleen Minhas, Sai Prasanna Narasimmal, Todd M. Bull, Teresa De Marco, John Wesley McConnell, Matthew R. Lammi, Thenappan Thenappan, Jeremy P. Feldman, Jeffrey S. Sager, David B. Badesch, John J. Ryan, Daniel C. Grinnan, Dianne Zwicke, Evelyn M. Horn, Jean M. Elwing, John E. Moss, Michael Eggert, Oksana A. Shlobin, Robert P. Frantz, Sonja D. Bartolome, Stephen C. Mathai, Sula Mazimba, Steven C. Pugliese, Nadine Al‐Naamani, PHAR investigators
Publikováno v:
Pulmonary Circulation, Vol 11, Iss 4, Pp 1-11 (2021)
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, morbid, potentially curable subtype of pulmonary hypertension that negatively impacts health‐related quality of life (HRQoL). Little is known about differences in HRQoL and hospitaliz
Externí odkaz:
https://doaj.org/article/7630fe6521244aa0b6585bc803767e68
Autor:
Hilary M. DuBrock, Charles D. Burger, Sonja D. Bartolome, Jeremy P. Feldman, David D. Ivy, Erika B. Rosenzweig, Jeffrey S. Sager, Kenneth W. Presberg, Stephen C. Mathai, Matthew R. Lammi, James R. Klinger, Michael Eggert, Teresa De Marco, Jean M. Elwing, David Badesch, Todd M. Bull, Linda M. Cadaret, Gautam Ramani, Thenappan Thenappan, H. James Ford, Nadine Al‐Naamani, Marc A. Simon, Sula Mazimba, James R. Runo, Murali Chakinala, Evelyn M. Horn, John J. Ryan, Robert P. Frantz, Michael J. Krowka, PHAR Investigators
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 4, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/ff7d574098134b25b2891ef16f2df205
Autor:
Nicholas S. Hill, Jeremy P. Feldman, Sandeep Sahay, Raymond L. Benza, Ioana R. Preston, David Badesch, Robert P. Frantz, Savan Patel, Ashley Galloway, Todd M. Bull, the INSPIRE study investigators
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 3, Pp n/a-n/a (2022)
Abstract The INSPIRE trial was a Phase 3, open‐label, multicenter trial (LTI‐301) that enrolled patients with pulmonary arterial hypertension (PAH) ≥ 18 years of age who transitioned to Yutrepia from nebulized treprostinil (Transition) or added
Externí odkaz:
https://doaj.org/article/d3d486acf448475aa616783826502355
Autor:
Hilary M. DuBrock, Charles D. Burger, Sonja D. Bartolome, Jeremy P. Feldman, D. Dunbar Ivy, Erika B. Rosenzweig, Jeffrey S. Sager, Kenneth W. Presberg, Stephen C. Mathai, Matthew R. Lammi, James R. Klinger, Michael Eggert, Teresa De Marco, Jean M. Elwing, David Badesch, Todd M. Bull, Linda M. Cadaret, Gautam Ramani, Thenappan Thenappan, H. James Ford, Nadine Al-Naamani, Marc A. Simon, Sula Mazimba, James R. Runo, Murali Chakinala, Evelyn M. Horn, John J. Ryan, Robert P. Frantz, Michael J. Krowka
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
Compared to idiopathic pulmonary arterial hypertension (IPAH), patients with portopulmonary hypertension (POPH) have worse survival. Health disparities may contribute to these differences but have not been studied. We sought to compare socioeconomic
Externí odkaz:
https://doaj.org/article/0eb2fcb1424a48d382c3a48edad8720f
Autor:
Jeremy P. Feldman, Mardi Gomberg-Maitland, Shelley M. Shapiro, Amy A. Lautenbach, Marty Morris, Jeff A. Murphy, Aaron B. Waxman, Robert C. Bourge
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
The implanted system for treprostinil has been described in previous publications. There is no information published about how to handle this system around lung or heart–lung transplantation. We present the experience from the DelIVery for Pulmonar
Externí odkaz:
https://doaj.org/article/a1581cb080924aa99ff9d7e56d8838b8
Autor:
Mardi Gomberg-Maitland, Robert C. Bourge, Shelley M. Shapiro, James H. Tarver, Dianne L. Zwicke, Jeremy P. Feldman, Murali M. Chakinala, Robert P. Frantz, Fernando Torres, Remzi Bag, Jeffrey A. Murphy, Amy A. Lautenbach, Marty Morris, Leigh Peterson, Aaron B. Waxman
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
Background The DelIVery for Pulmonary Arterial Hypertension clinical trial was a multi-center, prospective, single arm, Investigational Device Exemption study utilizing a fully implantable, programmable intravascular delivery system consisting of a p
Externí odkaz:
https://doaj.org/article/a1433a8c30ea4b7b98bec409679d6037
Publikováno v:
Respiratory Medicine Case Reports, Vol 21, Iss C, Pp 164-166 (2017)
Introduction: We present a 51 year old, African American, female who presented with persistent hypoxemia. She had been taking dapsone for many years for prophylaxis against Pneumocystic Jiroveci with no symptoms but eventually developed methemoglobin
Externí odkaz:
https://doaj.org/article/bc498b5ac927446e93d2dab07aad5aed
Autor:
HUNTER GILLIES, MURALI M CHAKINALA, BEN DAKE, JEREMY P FELDMAN, MARIUS M HOEPER, MARC HUMBERT, ZHI-CHENG JING, JONATHAN LANGLEY, VALLERIE MCLAUGHLIN, RALPH NIVEN, STEPHAN H. ROSENKRANZ, XIAOSHA ZHANG, NICHOLAS S HILL
Publikováno v:
Chest. 162:A2325-A2329